Alliancebernstein L.P. Collegium Pharmaceutical, Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 102,130 shares of COLL stock, worth $3.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,130

Previous 130,750 21.89%

Holding current value

$3.33 Million

Previous $4.21 Million 6.27%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $898,668 - $1.12 Million	-28,620 Reduced 21.89%	102,130 $3.95 Million
Q1 2024 May 14, 2024	SELL	$31.23 - $40.91 $906,919 - $1.19 Million	-29,040 Reduced 18.17%	130,750 $5.08 Million
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $246,789 - $359,220	11,663 Added 7.87%	159,790 $4.92 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $1.15 Million - $1.32 Million	54,227 Added 57.75%	148,127 $3.31 Million
Q2 2023 Aug 15, 2023	BUY	$21.06 - $24.0 $1.17 Million - $1.33 Million	55,600 Added 145.17%	93,900 $2.02 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $113,942 - $148,025	-4,954 Reduced 11.45%	38,300 $918,000
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $839 - $1,224	-52 Reduced 0.12%	43,254 $1 Million
Q3 2022 Nov 15, 2022	BUY	$15.46 - $20.1 $1,020 - $1,326	66 Added 0.15%	43,306 $694,000
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $554 - $814	-39 Reduced 0.09%	43,240 $766,000
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $2,580 - $3,375	150 Added 0.35%	43,279 $881,000
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $612 - $747	-35 Reduced 0.08%	43,129 $806,000
Q3 2021 Nov 10, 2021	SELL	$17.75 - $25.39 $28,045 - $40,116	-1,580 Reduced 3.53%	43,164 $852,000
Q1 2021 May 06, 2021	BUY	$19.25 - $26.1 $35,497 - $48,128	1,844 Added 4.3%	44,744 $1.06 Million
Q3 2020 Nov 12, 2020	SELL	$15.78 - $20.82 $971,416 - $1.28 Million	-61,560 Reduced 58.93%	42,900 $893,000
Q1 2020 May 14, 2020	SELL	$13.89 - $25.45 $472,954 - $866,572	-34,050 Reduced 24.58%	104,460 $1.71 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $54,864 - $71,712	5,400 Added 4.06%	138,510 $1.59 Million
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $223,763 - $349,551	21,070 Added 18.81%	133,110 $1.75 Million
Q1 2019 May 14, 2019	BUY	$13.58 - $18.72 $189,984 - $261,892	13,990 Added 14.27%	112,040 $1.7 Million
Q4 2018 Feb 13, 2019	BUY	$14.78 - $19.68 $899,363 - $1.2 Million	60,850 Added 163.58%	98,050 $1.68 Million
Q2 2018 Aug 13, 2018	BUY	$21.79 - $28.29 $41,401 - $53,751	1,900 Added 5.38%	37,200 $887,000
Q1 2018 May 14, 2018	BUY	$18.15 - $29.21 $139,755 - $224,917	7,700 Added 27.9%	35,300 $902,000
Q3 2017 Nov 13, 2017	BUY	$9.15 - $11.97 $252,540 - $330,372	27,600	27,600 $290,000

Others Institutions Holding COLL

# of Institutions

249

Shares Held

36.2M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Collegium Pharmaceutical, Inc Transaction History